The QualityStocks Daily Thursday, April 18th, 2019

Today's Top 3 Investment Newsletters

MarketClub Analysis (MBIO) +112.03%

PoliticsAndMyPortfolio (AMRS) +20.10%

NetworkNewsWire (BKI) +16.67%

The QualityStocks Daily Stock List

Tofutti Brands, Inc. (TOFB)

Zacks, Simply Wall St, 4-Traders, Financial Content, Stockhouse, Stock Invest, Wallet Investor, Market Screener, Dividend Investor, Marketbeat, Capital Cube, and InvestorsHub reported earlier on Tofutti Brands, Inc. (TOFB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tofutti Brands, Inc. develops and distributes a complete line of plant-based products. It sells greater than 35 milk-free foods. These include cheese products, frozen desserts, as well as prepared frozen dishes. The Company's products are available throughout the U.S. and in over 30 countries. Tofutti Brands answers the call of millions of people who are allergic or intolerant to dairy, diabetic, kosher or vegan, and also those who desire to have a healthier low-fat diet. OTCQB-listed and founded in 1981, Tofutti Brands is headquartered in Cranford, New Jersey.

The Company's product line includes plant-based ice cream pints, cones, Tofutti Cutie® sandwiches and novelty bars. In addition, Tofutti sells a prepared food entrée, Mintz's Blintzes®, made with Tofutti's milk-free cheeses such as Better Than Cream Cheese® and Sour Supreme®.

All of the Company's products are certified Kosher Parve. This means that none of its products ever contain any dairy whatsoever. This means no milk by-products either, such as casein, whey, skim milk powder, or dairy lactic acid. Tofutti Brands sells its products via independent unaffiliated food brokers to distributors, and on a direct basis to retail chain accounts or to warehouse accounts that directly service chain accounts.

Recently, Tofutti Brands issued its results for the Fiscal Year (FY) ended December 29, 2018. It reported Net Income of $507,000 ($0.10 per share) on Net Sales of $13,066,000 for the FY ended December 29, 2018, versus Net Income of $704,000 ($0.14 per share) on Net Sales of $14,107,000 for the FY ended December 30, 2017.

Sales of vegan cheese products decreased to $10,811,000 in fiscal 2018 from $11,237,000 in fiscal 2017. Sales of the Company's frozen dessert and frozen food product lines decreased to $2,255,000 in fiscal 2018 from $2,870,000 in fiscal 2017.

Mr. David Mintz, the Chairman and Chief Executive Officer of Tofutti Brands, said, "Despite a number of events that impacted the sales of our Better Than Cream Cheese, Sour Supreme and frozen dessert products, we were able to report net income of $507,000 in fiscal 2018. We believe that these issues are substantially behind us. We plan to introduce our new Dippity Do Dah Cheese Dips and reintroduce our Tofutti MarryMe Bars, Chocolate Fudge Treats, and Totally Fudge Pops in the second quarter of 2019 in time for the summer season and look forward to a better 2019."

Tofutti Brands, Inc. (TOFB), closed Thursday's trading session at $1.85, up 12.12%, on 152 volume with 2 trades. The average volume for the last 3 months is 1,730 and the stock's 52-week low/high is $1.45/$3.17.

chart

Pacific Health Care Organization, Inc. (PFHO)

NetworkNewsWire, Zacks, Infront Analytics, 4-Traders, Research Pool, Dividend Investor, Wallet Investor, Whale Wisdom, Journal Transcript, Investor Guide, Capital Cube, Market Screener, Simply Wall St, Marketbeat, Trading View, Stockhouse, and InvestorsHub reported beforehand on Pacific Health Care Organization, Inc. (PFHO), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Pacific Health Care Organization, Inc., by way of its subsidiaries, engages in managing and administering health care organizations (HCOs) and managed provider networks in California. The HCOs are networks of medical providers established to serve the workers' compensation industry. The Company, via its two HCOs, offers injured workers a choice of enrolling in an HCO with a network managed by primary care providers requiring a referral to specialists; or a second HCO, where injured workers do not require any prior authorization to be seen and treated by specialists. Incorporated in 1970, Pacific Health Care Organization has its head office in Newport Beach, California.

Via its wholly-owned subsidiaries, Pacific Health Care provides a variety of effective workers' compensation cost containment services. These include, but are not limited to, Health Care Organizations, Medical Provider Networks, HCO + MPN, Workers' Compensation Carve-Outs, Utilization Review, Medical Bill Review, Nurse Case Management, Lien Representation, Legal Support and Medicare Set-Aside services.

Fundamentally, Pacific Health Care specializes in workers' compensation cost containment. Its aim is to deliver value to its clients, which decreases their workers' compensation related medical claims expense in a way that will assure that injured employees receive high quality healthcare that allows them to recover from injury and return to gainful employment without unnecessary delay.

The Company's subsidiaries are Medex Health Care, Medex Managed Care, Medex Medical Management, Medex Legal Support, and Industrial Resolutions Coalition, Inc. (IRC). The two HCO certifications obtained by Medex cover the entire State of California.

The Company's two HCO certified programs have contracted with more than 3,900 individual providers and clinics, and also hospitals, pharmacies, rehabilitation centers and other ancillary services. This makes its HCOs capable of providing complete medical services throughout this region. The Company is continually developing these networks based upon the nominations of new clients and the approvals of their claims' administrators. Medex performs provider credentialing.

Recently, Pacific Health Care Organization filed with the Securities and Exchange Commission its annual report on Form 10-K announcing financial results for the Fiscal Year ended December 31, 2018. It reported total Revenue of $6,796,913 for the year ended December 31, 2018, versus $6,505,527, of total Revenue for the year ended December 31, 2017. It reported Net Income of $1,359,777 or $0.42 per basic and fully diluted shares for the year ended December 31, 2018, versus Net Income of $964,405 or $0.30 per basic and fully diluted share for the year ended December 31, 2017.

Pacific Health Care Organization, Inc. (PFHO), closed Thursday's trading session at $5.10, up 2.00%, on 500 volume with 3 trades. The average volume for the last 3 months is 546 and the stock's 52-week low/high is $2.75/$5.95.

chart

Cannex Capital Holdings, Inc. (CNXXF)

Small Cap Power, Midas Letter, Insider Financial, InvestorsHub, Barchart, Trading View, Wallet Investor, Investing News, Simply Wall St, Stockhouse, Stockwatch, GuruFocus, Pot Stock News, MarketWatch, and New Cannabis Ventures reported beforehand on Cannex Capital Holdings, Inc. (CNXXF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Cannex Capital Holdings, Inc., via its wholly-owned subsidiaries, provides real estate, management, financial, branding and IP support to its increasing portfolio of licensed cannabis business operators. The Company leases real estate properties and sells supplies to cannabis cultivators, processors, and dispensaries in the U.S. and Canada. Cannex Capital Holdings' shares trade on the OTC Markets Group's OTCQX. The Company is headquartered in Vancouver, British Columbia.

Cannex engages in the provision of turn-key real estate with operational infrastructure; cannabis growing-related consulting services; purchasing agent services; and the sale of packaging and other non-cannabis product inputs, including soil, indoor lighting, and packaging. The Company is undertaking expansion initiatives to support the acquisition and development of additional assets in legal medical and recreational cannabis markets.

At present, Cannex Capital Holdings owns BrightLeaf Development LLC. BrightLeaf holds real estate assets, property leases, intellectual property, and material supply agreements with licensed cannabis businesses. This includes Superior Gardens LLC (d/b/a Northwest Cannabis Solutions), one of the Pacific Northwest's largest full-line cannabis producer/processors.

In November 2018, Cannex Capital Holdings announced that it signed a binding letter agreement (the Interim Agreement) pursuant to which 4Front Holdings, LLC agreed to combine with Cannex in an all-stock transaction. Subject to the approval of the Canadian Securities Exchange (CSE), the combined company will continue to trade on the CSE initially under Cannex's existing name and the ticker symbol CNNX. The Interim Agreement will be superseded by a definitive governing the Transaction.

4Front Holdings is a foremost retail and brand development company in the U.S. cannabis sector. 4Front has developed a national platform, which comprises a multi-state footprint, including its Mission-branded retail operations, and an extensive network of partnership relationships.

This month, 4Front Holdings announced the proposed Board of Directors of the new public 4Front company that will survive after the completion of its planned business combination with Cannex Capital Holdings. Upon closing, the resulting issuer will be formally named 4Front Ventures Corporation. The Board of 4Front Ventures will initially consist of five Directors, with Cannex Capital Holdings and 4Front Holdings each appointing one Director and mutually agreeing on three additional Directors.

Cannex Capital Holdings, Inc. (CNXXF), closed Thursday's trading session at $1.79, down 3.24%, on 194,223 volume with 110 trades. The average volume for the last 3 months is 225,898 and the stock's 52-week low/high is $0.378/$2.25.

chart

FingerMotion, Inc. (FNGR)

Stockhouse, Capital Cube, Market Screener, OTC Markets, InvestorsHub, Stockwatch, 4-Traders, Real Investment Advice, YCharts, Stockopedia, Wallet Investor, MarketWatch, and Simply Wall St reported previously on FingerMotion, Inc. (FNGR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FingerMotion, Inc. is a mobile payment and recharge platform company listed on the OTCQB. It is one of five companies in China with access to wholesale rechargeable minutes via top-up credits on the mobile phone. FingerMotion is developing value added technologies to market to its users. The Company eventually hopes to serve greater than 1 billion users in the China market and eventually expand the model to other regional markets. FingerMotion is based in Wan Chai, Hong Kong.

FingerMotion's corporate vision is to quickly grow the user base by way of organic means and have this growth develop into an ecosystem of users with high engagement rates using its unique applications. The Company states that developing a highly engaged ecosystem of users would strategically position FingerMotion to onboard larger customer bases and eventually drive a consolidation of the top five wholesalers.

The Company is investing in research and development (R&D). Its main area of focus is the development of "must have" applications for consumers and businesses. FingerMotion's longer term focus is to develop a marketing platform that can take advantage of all the meta data collected by the top telcos into a predictive model, which is able to isolate and extract consumer behavior and habits for future monetization.

This past February, Finger Motion announced that its top-up platform for China Unicom, which derives a majority of its Gross Transaction Volume (GTV) from PingDuoDuo (PDD), is fully operational, generating 20 million RMB (USD 3.0 million) in GTV daily. This is a major increase in the daily platform activity that had earlier generated 13.25 million RMB (USD 1.95 million) in GTV.

PingDuoDuo is an inventive e-commerce platform based in China. It offers consumers an enjoyable and interactive shopping experience, which also offers bargain pricing. PingDuoDuo's platform has accumulated over 385.5 million members and 2 million merchants, with an annual transaction value of 344.8 billion yuan (USD $51 Billion Dollars).

In March, Finger Motion announced that it realized record gross transaction volume (GTV) of $115 million in its Q4 ended February 28, 2019. This is roughly 32 percent higher than in the previous quarter. Moreover, the Company received more than $750,000 in private placements from new and existing accredited investors.

FingerMotion, Inc. (FNGR), closed Thursday's trading session at $6.30, up 5.00%, on 3,464 volume with 11 trades. The average volume for the last 3 months is 7,196 and the stock's 52-week low/high is $1.98/$8.50.

chart

Gran Colombia Gold Corp. (TPRFF)

Gold Stock Data, Market Screener, Canadian Mining Report, Metals News, Stockhouse, GlobeNewswire, InvestorsHub, Wallet Investor, Junior Mining Network, Equity Clock, and Investors Hangout reported previously on Gran Colombia Gold Corp. (TPRFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Gran Colombia Gold Corp. is a mid-tier gold producer headquartered in Toronto, Ontario. The Company's main focus is in Colombia where it is presently the largest underground gold and silver producer with a number of mines in operation at its Segovia and Marmato Operations. Gran Colombia is continuing to center on exploration, expansion and modernization activities at its high-grade Segovia Operations. The Company lists on the OTC Markets' OTCQX.

Gran Colombia Gold is building a strong production growth profile by way of exploration, development and bringing to production gold projects in Colombia. Its emphasis is on the development of the Segovia Operations and Marmato projects to generate strong cash flows in the short, medium and long term.

The Company produces gold from the Segovia Operations, an area of roughly 9,000 hectares in the Segovia-Remedios mining district of Antioquia. The Segovia Operations include the El Silencio, Providencia and Sandra K underground mines in the Municipality of Segovia, and the Carla underground mine in the Municipality of Remedios, situated about 10 km southeast of the Segovia mines.

The Marmato Project contains total estimated resources of roughly 8 million ounces of gold and almost 38 million ounces of silver positioned in the Caldas department in the core of the Middle Cauca gold district. The Marmato Project has first-rate infrastructure, being located by the Pan American Highway with access to Medellin to the north and Manizales to the south. The Project also has access to the national electricity grid that runs near the property.

Gran Colombia Gold also has its Zancudo Project. It is in the Titiribí mining district of Antioquia. Zancudo consists of an historical gold mine, the Independencia Mine, in the Middle Cauca Gold Belt, which produced approximately 130,000 ounces of gold with recovered grades of 14.6 g/t Au and 108.4 g/t Ag.

Gran Colombia Gold halted further exploration work on the Zancudo property following the gold price collapse in 2013 to concentrate on the modernization project at its Segovia Operations. The Company announced in March of 2017 that it signed an option agreement with IAMGOLD Corp. for the exploration and potential purchase of an interest in the Zancudo Project.

Last week, Gran Colombia Gold announced that it produced a total of 21,325 ounces of gold in March 2019. This brings the total for Q1 of 2019 to 60,601 ounces, a new quarterly record and up 15 percent over Q1 of 2018. This brings the trailing 12 months' total gold production at the end of March 2019 to 225,930 ounces. This is up 4 percent over 2018's annual production and at the top end of Gran Colombia Gold's guidance range for 2019 of between 210,000 and 225,000 ounces.

Gran Colombia Gold will release its financial results for Q1 of 2019 after market close on Wednesday, May 15, 2019. The Company will host a conference call and webcast on Thursday, May 16, 2019 at 9:30 a.m. Eastern Time to discuss the results.

Gran Colombia Gold Corp. (TPRFF), closed Thursday's trading session at $2.45, up 3.81%, on 17,710 volume with 15 trades. The average volume for the last 3 months is 26,783 and the stock's 52-week low/high is $1.566/$3.44.

chart

Mechanical Technology, Incorporated (MKTY)

Zacks, Wallet Investor, Tech Stock Standard, Business Wire, Last10k, InvestorsHub, Marketbeat, Biz Journals, Simply Wall St, YCharts, The Street, MarketWatch, Dividend Investor, Marketwired, and Market Screener reported previously on Mechanical Technology, Incorporated (MKTY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mechanical Technology, Incorporated engages in the design, manufacture, and sale of test and measurement instruments and systems via its subsidiary MTI Instruments Incorporated. It designs, manufactures, and markets precision linear displacement solutions, vibration measurement and system balancing solutions, precision tensile measurement systems, and wafer inspection tools globally. The Company lists on the OTC Markets. Established in 1961, Mechanical Technology has its head office in Albany, New York.

MTI Instruments' products use a complete variety of technologies to solve complex, real world applications in manifold industries. These industries include manufacturing, electronics, semiconductor, solar, commercial and military aviation, automotive and data storage.

MTI offers electronic gauging instruments for position, displacement, and vibration applications in the industrial manufacturing/production markets, and the research, design, and process development market. Additionally, MTI provides engine balancing and vibration analysis systems for military and commercial aircraft; and metrology tools for semiconductor and solar wafer characterization. It also provides tensile stage systems for materials testing and precision linear displacement gauges for use in academic and industrial research and development settings.

Recently, Mechanical Technology announced its financial results for 2018. Revenue increased $1.0 million, or 14 percent, to $8.1 million in 2018 because of increased activity with the U.S. government. The Company continues to expand its PBS product offerings within existing and new Air Force, Navy and Coast Guard programs. The Company also continued to grow its commercial engine balancing system and accessories business, most notably in engine test cell facilities worldwide.

Operating Income grew $935,000 in 2018 to $1.5 million. This is the highest level reported by the Company since 1998. Spending on new development initiatives and product enhancements at its MTI Instruments subsidiary intensified in 2018 as part of Mechanical Technology's commitment to grow organically. Therefore, 2019 will see the introduction of new capacitance products and an updated model of the Company's renowned engine vibration balancing system.

Mechanical Technology, Incorporated (MKTY), closed Thursday's trading session at $1.30, up 8.33%, on 3,112 volume with 6 trades. The average volume for the last 3 months is 18,688 and the stock's 52-week low/high is $0.57/$1.70.

chart

Rubicon Organics, Inc. (ROMJF)

CannabisFN, Investorx, Investor Ideas, PR Newswire, Investor News, Pot Stock News, Stockhouse, Trading View, Stockwatch, Market Screener, Biospace, The Street, and Investors Hangout reported earlier on Rubicon Organics, Inc. (ROMJF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Rubicon Organics, Inc. is a super-premium, organic cannabis producer with operations in Canada, Washington and California. The Company is a Licensed Producer (LP) and its flagship Canadian facility is a 125,000 sq. ft. state-of-the-art hybrid greenhouse with industry leading LED lighting. This facility is situated on a 20-acre property in Delta, British Columbia. Furthermore, Rubicon Organics owns two award-winning U.S. cannabis brands. These are 1964 Supply Co. (TM) in California and Doctor & Crook Co. (TM) in Washington. OTCQX-listed and founded in 2015, Rubicon Organics is based in Vancouver, British Columbia.

Rubicon's Washington facility is a newly constructed, 40,000 sq. ft. hybrid greenhouse and extraction facility. The Company has started production in both facilities with a combined Phase I capacity of 15,500 kg per year. This includes 4,500 kg leased to a Washington State licensed operator applying Rubicon Organics' proprietary organic cultivation methods (Organic certification pending from FVOPA).

The Company's plants are grown in proprietary soil made with certified organic ingredients. Each stage of the growing process is carried out by hand - from planting to packaging. Rubicon's process replicates outdoor growing techniques. The process is supervised by skilled and knowledgeable growers. Moreover, everything that goes into its plants comes from the ground and the ocean.

Rubicon Organics is the first cannabis operation in Canada to complete an Environmental Farm Plan. This comprises 100 percent rainwater collection and recycling; carbon capture and reuse; and net-zero energy and waste.

Last month, Rubicon Organics announced that its 125,000 sq. ft. licensed facility in Delta, British Columbia started preparation for its European Union - Good Manufacturing Practices (EU-GMP) certification. The EU-GMP certification is given to companies who demonstrate a high degree of precision and consistency in their manufacturing procedures. It is a requirement for the import of medical cannabis products into the European market.

In addition, last month, Rubicon Organics announced its membership in the Global Cannabis Partnership (GCP). The Global Cannabis Partnership is a collaboration of leaders in the government-sanctioned adult-use recreational cannabis industry. It has representation from government, private-sector and affiliate organizations. The GCP works to create global standards for the safe and responsible production, distribution and consumption of legal recreational cannabis.

Rubicon Organics, Inc. (ROMJF), closed Thursday's trading session at $2.19, up 0.46%, on 220 volume with 3 trades. The average volume for the last 3 months is 7,219 and the stock's 52-week low/high is $1.298/$2.50.

chart

Eco Tek 360, Inc. (ECTX)

Penny Stock Hub, Stockhouse, Barchart, Market Screener, MarketWatch, Investors Hangout, Simply Wall St, InvestorsHub, Street Insider, The Street, Capital Cube, Wallstreet Online, Trading View, InvestingOnline, Wallmine, Stockopedia, GuruFocus, and Wallet Investor reported earlier on Eco Tek 360, Inc. (ECTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2004, Eco Tek 360, Inc. provides modern, sustainably sourced casual clothing. The Company's patented green technology allows it to provide sustainable uniforms. Eco Tek 360 centers on providing branded fabrics, apparel, and uniforms to the corporate, hotel, hospital, as well as military markets. Its on site design, pattern making, and tech pack construction allows for increased efficiency and reduced lead times through creating patterns and tech packs in-house.

The Company previously went by the name Global Fashion Technologies, Inc. It changed its name to Eco Tek 360, Inc. in January of 2017. Tek 360 is based in Somerville, New Jersey. The Company's shares trade on the OTC Markets Group's OTCQB.

Eco Tek 360's state-of-the-art green technology allows it to collect and rejuvenate a customer's used uniforms into new uniforms. The Company rejuvenates old uniforms and recovers the fiber to spin yarn, make fabric, and cut and sew new uniforms in its U.S. based facility.

Its quality process is integrated from the collection of customers' old uniforms via delivery to them from its New Jersey warehouse. Its in-house capabilities ensure versatility, first-rate design, and responsiveness to support small batch construction for specialty products, unique sizing, and also personalization with quick turn times.

Eco Tek 360's program for its customers is a four-step process. This process includes 1.Recovery; 2. Rejuvenation; 3. Re-Creation; and 4. Shipping.

Concerning Recovery, a customer collects/recovers their old uniforms and sends them to Eco Tek 360. Through controlling their used uniforms, a customer improves their security. They receive a credit that is good toward their subsequent uniform purchase.

Regarding Rejuvenation, Eco Tek 360's patented process purifies old fiber into new, sustainably-sourced uniforms. This rejuvenated fiber is soft and strong, and it saves 6,200 liters per cotton shirt.

Concerning Re-Creation, the Company cuts and sews new uniforms from the rejuvenated fiber. Pertaining to Shipping, a customer's new uniforms are ready for purchasing in Eco Tek 360's secure online store. They are shipped directly to the customer.

Eco Tek 360, Inc. (ECTX), closed Thursday's trading session at $0.248, up 1,027.27%, on 100 volume with 1 trade. The average volume for the last 3 months is 2,103 and the stock's 52-week low/high is $0.022/$0.5395.

chart

Isodiol International, Inc. (ISOLF)

SmallCapPower, Investors News, OTC Markets, Wallet Investor, Barchart, MarketWatch, Investopedia, Stockhouse, Stockwatch, Morningstar, Trading View, Wealth Daily, Investing News, MicroSmallCap, Proactive Investors, The Street, InvestorsHub, and GuruFocus reported earlier on Isodiol International, Inc. (ISOLF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Isodiol International, Inc. specializes in the development of pharmaceutical and wellness products. Its growth strategy includes the development of Over-the-Counter (OTC) and pharmaceutical drugs and expanding its phytoceutical portfolio. Be Trū Wellness is a wholly-owned subsidiary of the Company. Isodiol is continuing international expansion into Latin America, Asia, and Europe. A global CBD innovator and OTCQB-listed, Isodiol International is headquartered in Vancouver, British Columbia.

Isodiol International specializes in hemp-based health and wellness products and the development of pharmaceutical CBD delivery methods. In addition, the Company specializes in the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs).

Isodiol is the market leader in pharmaceutical grade phytochemical compounds. It is also the industry leader in the manufacturing and development of phytoceutical consumer products. Isodiol produces raw ingredients, consumer packaged goods, including dietary supplements, food and beverages, skin care, and pharmaceutical products for the worldwide healthcare market.

Regarding raw ingredients, Isodiol develops natural phytoceutical derivatives and delivery technologies. Additionally, it develops white label products and brands for wholesale customers. Concerning pharmaceuticals, the Company supplies raw phytoceutical ingredients. Pertaining to consumer products, it develops its own family of product brands for retail sale.

Isodiol has its ImmunAG™. This product is the market's first non-cannabis cannabidiol (CBD) product derived from the hops plant. This is a time-released tablet. The ImmunAG tablet does not dissolve in the stomach. It dissolves in the lower intestine, thus creating greater bioactivity.

Isodiol has acquired global licensing rights for IsoDerm™ and five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology™. This is a back of the neck delivery system from its developer Dr. Ronald Aung-Din, MD.

Last week, Isodiol International announced the acquisition of the CBD Naturals® beverage brands and intellectual property (IP) portfolio. This includes Hemp Rain, Rasa, Bliss Me, Fast CBD, and Simplex. This deal includes additional financing from the Company's founder, Jared Berry, to be used for guaranteed product placement in greater than 1,000 U.S. retail locations. The transactions include the transfer to Isodiol International's subsidiaries of substantially all of the IP and inventory of Carlsbad Naturals LLC, a Wyoming limited liability company (Carlsbad WY), and Carlsbad Naturals LLC, a New Mexico limited liability company (Carlsbad NM).

Isodiol International, Inc. (ISOLF), closed Thursday's trading session at $0.9975, up 0.76%, on 131,805 volume with 105 trades. The average volume for the last 3 months is 174,764 and the stock's 52-week low/high is $0.783/$8.899.

chart

Mountain High Acquisitions Corp. (MYHI)

Wealth Insider Alert, SmallCapVoice, Wallstreet Profiler, FivedollarMovers, Stockgoodies, Laissez Faire Today, Integrity Solution IR, Cannabis Financial Network, TopPennyStockMovers, Market Intelligence Center, Charms Investments, StreetAuthority Daily, and PennyDoctor reported earlier on Mountain High Acquisitions Corp. (MYHI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mountain High Acquisitions Corp. is a turnkey, pioneering infrastructure provider to licensed cannabis growers, processors, and producers in regulated markets. The Company assists in the design, permitting, development, and operation of scalable infrastructure. OTCQB-listed, Mountain High Acquisitions is based in Scottsdale, Arizona.

Additionally, the Company helps licensed operators take advantage of scientific and technological innovations specifically geared to optimize the cultivation and processing of cannabis. In 2017, Mountain High Acquisitions entered into an agreement with D9 Manufacturing, Inc. D9 Manufacturing is an Arizona-based business that provides a wide variety of engineering, manufacturing, and consulting services to the cannabis sector.

Mountain High Acquisitions engaged D9 Manufacturing to assist in the identification, acquisition, and development of infrastructure and technology opportunities in the emerging cannabis market. Mountain High, together with D9 Manufacturing, has launched a pilot project targeted at proving a turnkey infrastructure model Mountain High intends to launch in highly promising cannabis markets. This includes California, Washington, and Arizona. The goal is to assist licensed cannabis growers in overcoming the key business challenge of financing steep start-up infrastructure expenses.

Mountain High Acquisitions has expanded its pilot program focused on providing turnkey infrastructure solutions to licensed cannabis growers. With the help of D9 Manufacturing, the program agenda has expanded to include the development of reliable Standard Operating Procedures (SOPs), which growers will be able to use to substantially reduce the risk of low yield or failed grows. D9 Manufacturing is concentrating on fine-tuning SOPs and best practices.

Mountain High Acquisitions announced in August of 2018 that it closed on the acquisition of One Lab Co. One Lab is a Nevada-based company that provides extraction equipment to the cannabis industry.

This past November, Mountain High Acquisitions announced that its wholly-owned subsidiary One Lab Co. completed delivery of a state-of-the-art modular extraction lab to Workforce Labor Solutions, LLC (WLS). WLS provides turnkey labor and extraction services to licensed cannabis producers in Washington State. According to the terms of the five-year lease with One Lab, WLS will make payments of $25,000 per month for use of the lab.

Mountain High Acquisitions Corp. (MYHI), closed Thursday's trading session at $0.019, down 4.62%, on 495,535 volume with 44 trades. The average volume for the last 3 months is 460,846 and the stock's 52-week low/high is $0.016/$0.153.

chart

Auxly Cannabis Group, Inc. (CBWTF)

MicroSmallCap, The National Marijuana News, Marketbeat, The Street, Marijuana Index, Pot Network, Zacks, All Penny Stocks, OTC Markets, Investor Place, MarketWatch, Daily Marijuana Observer, InvestorsHub, Stockhouse, Marijuana Stox, TradingView, Wallmine, and 4-Traders reported earlier on Auxly Cannabis Group, Inc. (CBWTF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Auxly Cannabis Group, Inc. operates as a cannabis streaming company. Its mandate is to nurture growth for its partners through providing them with financial support and sharing the Company's collective industry experience. Auxly Cannabis invests in and supports a wide spectrum of cannabis cultivation companies. The Company formerly went by the name Cannabis Wheaton Income Corp. It changed its name to Auxly Cannabis Group, Inc. in June of 2018. OTCQX-listed, Auxly Cannabis is based in Vancouver, British Columbia.

The Company has acquired an 80 percent ownership in Inverell S.A. providing Auxly with a long term, stable supply of CBD molecules to sell into its worldwide distribution channels. In addition, Auxly signed an international supply agreement with Aphria, Inc. to purchase up to 20,000 kilograms of cannabis products on a yearly basis, during the term of the agreement. 

The Company has established a foundational platform encompassing the entire cannabis value-chain, minimizing risk while simultaneously maximizing exposure to numerous, geographically-diverse cannabis companies via a single source. Auxly is using the stream, or streaming model, to finance cannabis companies.

Auxly provides financial support for cannabis facility expansions, operations, as well as initial construction. It does so in exchange for minority equity interests and a portion of the cultivation production. Auxly Cannabis partners maintain their brand autonomy. Moreover, they obtain access to better scaling flexibility.

Auxly Cannabis continues to acquire cultivation capacity through the development of facilities in Canada and Uruguay. The foundation of the Auxly platform is the development of a strong supply pipeline. The Company remains focused on building out its diverse cultivation platform consisting of wholly-owned assets, streaming partnerships, joint venture (JV) partnerships, and commercial offtake arrangements.

In January, Auxly Cannabis announced that it signed a definitive agreement with 2368523 Ontario Limited (d/b/a) Curative Cannabis. Auxly will acquire 46 percent of the common shares of Curative. It will enter into a long-term cannabis purchase and sale agreement to fund the construction and development costs of Curative's cannabis cultivation facility in Chatham-Kent, Ontario.

Yesterday, Auxly Cannabis announced the appointments of Mr. Brian Schmitt as Chief Financial Officer, Mr. Jason Sonshine as Vice President, Strategy, and Ms. Carla Nawrocki as Vice President, Investor Relations of Auxly Cannabis Group.

Auxly Cannabis Group, Inc. (CBWTF), closed Thursday's trading session at $0.62279, up 1.43%, on 820,728 volume with 400 trades. The average volume for the last 3 months is 1,347,840 and the stock's 52-week low/high is $0.444/$1.33.

chart

Humanigen, Inc. (HGEN)

Amigo Bulls, InvestorsHub, Barchart, Investors Hangout, Financial Times, Stock Invest, Corporate Information, Insider Financial, The Street, TradingView, OTC Markets, Investopedia, and Proactive Investors reported previously on Humanigen, Inc. (HGEN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Humanigen, Inc. focuses on advancing medicines for patients with neglected and rare diseases via unique, accelerated business models. Lead compounds in the Company's portfolio include the proprietary monoclonal antibodies, lenzilumab and ifabotuzumab. Derived from its Humaneered® platform, lenzilumab and ifabotuzumab are lead compounds in the portfolio of monoclonal antibodies with first-in-class mechanisms. OTCQB-listed, Humanigen is headquartered in Brisbane, California.

The Company pursues innovative science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments. Lenzilumab has potential for the treatment of different rare diseases. These include hematologic cancers such as chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML).

Lenzilumab is a Humaneered® recombinant monoclonal antibody. It neutralizes soluble granulocyte-macrophage colony-stimulating factor (GM-CSF). This is a crucial cytokine that drives the growth of certain hematologic malignancies.

The other important asset in Humanigen's monoclonal antibody portfolio, ifabotuzumab, has been dosed in the first patient in an investigator-sponsored Phase 0/1 radio-labeled imaging trial in glioblastoma multiforme (GBM). Ifabotuzumab is a first-in-class, monoclonal antibody. It targets the EphA3 receptor tyrosine kinase created using the Company's proprietary Humaneered® technology.

This past December, Humanigen announced that final results from the xenograft study of lenzilumab, a first-in-class anti-GM-CSF monoclonal antibody, were presented in the oral plenary session at the 2018 Annual Meeting of the American Society of Hematology, on December 3, 2018, by Rosalie Sterner from Mayo Clinic. The principal investigator for the study was Saad Kenderian, M.B., Ch.B., Mayo Clinic hematologist.

The abstract entitled "GM-CSF Blockade during Chimeric Antigen Receptor T Cell Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance Their Effector Functions" was published as a first edition paper by 'blood'® in the November 21, 2018 edition. It is available online here.

Last month, Humanigen announced that new research was published in the December issue of the journal Cancers demonstrating that the EphA3 receptor, the novel target for Humanigen's proprietary monoclonal antibody ifabotuzumab, is an attractive tumor-specific target for glioblastoma multiforme (GBM) therapy. In addition, the results suggest that ifabotuzumab may be therapeutically useful in the treatment of other solid tumors.

Dr. Cameron Durrant, Humanigen's Chief Executive Officer, said, "Brain cancer sufferers have not seen meaningful increases in overall survival for decades. By targeting the tumor stem cells, stromal cells and neovasculature, we believe ifabotuzumab has the potential to emerge as a next-generation oncology therapy."

Humanigen, Inc. (HGEN), closed Thursday's trading session at $1.40, up 3.70%, on 1,562 volume with 5 trades. The average volume for the last 3 months is 11,640 and the stock's 52-week low/high is $0.27/$1.544.

chart

Kutcho Copper Corp. (KCCFF)

InvestorX, Junior Stock Review, Investors Hangout, The Prospector News, Mining & Energy, Wallet Investor, OTC Markets, Resource Stock Digest, Market Screener, 4-Traders, Stateside Report, Junior Mining Network, Stock Orange, Resource World, Dividend Investor, Stockhouse, Barchart, Stockwatch, and MarketWatch reported previously on Kutcho Copper Corp. (KCCFF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Kutcho Copper Corp. concentrates on expanding and developing the Kutcho high grade copper-zinc project in northern British Columbia. The Company's intention is to progress the Kutcho Project through feasibility and permitting to a positive construction decision. A resource development company, Kutcho Copper is headquartered in Vancouver, British Columbia (B.C.).

The Kutcho Copper Project is Kutcho's 100 percent owned high grade copper-zinc development project in northern B.C. This Project is in a top tier mining jurisdiction with major mines and permitted projects in Tahltan and Kaska territories. Kutcho Copper has a Probable Reserve of 10.4 Mt grading 2.01% Cu and 3.19% Zn (2.92% CuEq).

The Kutcho Copper Project has a Mine Life of 12 years. Its Production Rate is 2,500 tpd. The Project has low risk potential to increase Mineral Reserves and substantially increase production capacity.

The Wheaton Precious Metals stream establishes a basis for a strong partnership and lessens financial risk of the Project. Furthermore, there is the potential for more discoveries via exploration. Kutcho Copper's objective is to increase reserves from the present 10.4 Mt through existing resource conversion.

Kutcho Copper has launched MineHub Technologies, Inc. with a syndicate of industry partners. This includes a senior mining company, one of the world's largest streaming companies, a global base and precious metals and concentrates trading company and an international financial institution providing banking services in the metals and mining industry. MineHub is a leading-edge technology company taking advantage of blockchain technology to develop a new generation of applications for the metals and mining industry.

Last month, MineHub Technologies and IBM announced a collaboration to use blockchain technology to help improve operational efficiencies, logistics and financing and decrease costs in the high-value mineral concentrates supply chain - from mine to end buyer. Kutcho Copper, Goldcorp, Inc., ING Bank, Ocean Partners USA, Inc. and Wheaton Precious Metals are working with mining technology company MineHub to build the new mining supply chain solution on top of the IBM Blockchain Platform.

In addition, in January, Kutcho Copper announced it appointed Mr. Michael Rapsch as Vice President of Corporate Communications. Mr. Rapsch has a decade of in-depth investor relations and corporate communications experience.  Before joining Kutcho Copper he held the position of Vice President, Corporate Communications at SilverCrest Metals, Inc. for the last three years.

Kutcho Copper Corp. (KCCFF), closed Thursday's trading session at $0.19, up 11.37%, on 23,350 volume with 5 trades. The average volume for the last 3 months is 33,635 and the stock's 52-week low/high is $0.143/$0.496.

chart

Beleave, Inc. (BLEVF)

NetworkNewsWire, Research Pool, TradingView, Marketwired, Penny Stock Tweets, OTC Markets, New Cannabis Ventures, Equities, MarketWatch, Morningstar, 4-Traders, Midas Letter, Daily Marijuana Observer, Weed Newswire, Wallet Investor, The Street, InvestorsHub, Business Insider, Investing News, Cannabis Newswire, Investors Hangout, Stockhouse, Barchart, and Primed Equities reported previously on Beleave, Inc. (BLEVF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Beleave, Inc. is a diversified biotechnology company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario. Additionally, the OTCQX-listed Company has patient services clinics operating throughout Ontario under the Medi-Green brand. Its wholly-owned subsidiary is Beleave Kannabis Corp. Beleave earlier closed on the acquisition of the Medi-Green Cannabis Clinic Network. London, Ontario is Beleave's fourth clinic joining three Ontario locations already open in Hamilton, Kingston, and Perth. Beleave is headquartered in Oakville, Ontario.

Beleave has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market in 2019. Its Hamilton, Ontario laboratory is undergoing expansion to make room for methods to formulate cannabis extracts into soluble, flavorless powders, sugar crystals, and syrups for use in beverages and food products using stability-enhancing techniques for prolonged shelf-life.

The Company's aim is to provide a consistent, reliable and standardized product to suit the needs of every person. Beleave concentrates on green initiatives. It grows its plants using no pesticides. Furthermore, its facilities host a large-scale, commercial, solar installation that substantially offsets its carbon footprint. Beleave's water supply is on a closed loop system to recycle every drop.

Beleave's products include Shishkaberry, CBD god bud, and Cold Creek Kush. Shiskaberryʼs buds have a fruit and berry aroma with shades of purple. CBD god bud was created by mixing an almost pure Sativa strain named Hawaiin with a very strong purple Indica strain. Cold Creek Kush is an Indica-dominant hybrid. It crosses the strong MK Ultra and Chemdawg 91.

In July of 2018, Beleave announced the acquisition of 100 percent of the outstanding shares of Seven Oaks, Inc. This acquisition follows important news of Seven Oaks branded cannabis products being chosen by Manitoba Liquor and Lotteries Corporation and the BC Liquor Distribution Branch for sale to consumers in deals expected to produce initial revenues of more than $2,900,000. Beleave will offer Seven Oaks-branded cannabis flower, pre-rolls, and oils.

Beleave announced this past November that it secured genetics acquisition agreements for a broad assortment of cannabis seed varieties from different lineages. There will be 90 new varieties introduced in 2019. These have been selected to cover the entire spectrum of low, intermediate, and high THC and CBD profiles.

In January of this year, Beleave announced that its wholly-owned subsidiary Beleave Kannabis was authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended license with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations.

Beleave, Inc. (BLEVF), closed Thursday's trading session at $0.078, up 6.64%, on 104,675 volume with 24 trades. The average volume for the last 3 months is 274,277 and the stock's 52-week low/high is $0.05/$0.25.

chart

The QualityStocks Company Corner

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Trxade Group (OTCQB: TRXD), an integrated pharmaceutical services company, delivers a synergistic combination of product offerings and superior data analytics. To view the full article, visit: http://nnw.fm/bCv47.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed the day's trading session at $0.45, even for the day, on 5,101 volume. The average volume for the last 3 months is 2,183 and the stock's 52-week low/high is $0.23/$1.00.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Canadian licensed producer of premium cannabis products, maintains its goal of non-irradiation using production methods that are anticipated to produce high crop yields at low operating costs.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $6.75, up 2.27%, on 68,174 volume with 167 trades. The average volume for the last 3 months is 292,779 and the stock's 52-week low/high is $2.74/$8.42.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) today announced that it has entered into a sub-lease agreement for 10,000 square feet of an Adelanto, California-based multipurpose facility. To view the full press release, visit: http://nnw.fm/Gy5RR.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $6.28, up 2.78%, on 100,995 volume with 195 trades. The average volume for the last 3 months is 150,778 and the stock's 52-week low/high is $0.769/$6.28.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Cannabis product manufacturer Plus Products (CSE: PLUS) (OTCQB: PLPRF) this morning announced a new line of mints as well as the launch of the first flavor, Classic Mint. PLUS Classic Mints contain 2.5 mg THC and less than 0.1 mg CBD each. To view the full press release, visit: http://nnw.fm/CI3Kl.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $4.12, up 1.98%, on 54,794 volume with 137 trades. The average volume for the last 3 months is 81,846 and the stock's 52-week low/high is $2.81/$6.01.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc., (CSE: GGB) (OTCQB: GGBXF) ("GGB" or "the Company") a cannabis and CBD retailer specializing in creating remarkable consumer experiences, announced today the launch of CAMP™, a proprietary cannabis brand. Also today, the company was featured in the 420 with CNW by CannabisNewsWire.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.30, up 10.00%, on 800,653 volume with 2,046 trades. The average volume for the last 3 months is 199,964 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTCQB: GRYN), a full-scope, premium cannabis company targeting the high-end medical and recreational adult-use market, is moving quickly to establish itself as a leader in the advancement of science-driven cannabis cultivation techniques. Underscoring the company's strategy of generating revenues from multiple sources, including valuable acquisitions, is the decision to acquire Las Vegas, Nevada-based Coastal Labs, according to a news release (http://nnw.fm/X1j30). Also today, the company was featured in the 420 with CNW by CannabisNewsWire.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.698, up 4.33%, on 6,433 volume with 9 trades. The average volume for the last 3 months is 27,750 and the stock's 52-week low/high is $0.07/$0.722.

Recent News

chart

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF).

Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to provide shareholders with an update on the Company's Washington State assets and its Desert Hot Springs, California cultivation facility development.

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.53925, up 1.82%, on 168,836 volume with 124 trades. The average volume for the last 3 months is 47,896 and the stock's 52-week low/high is $0.268/$0.605.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

International anxiety about planetary climate change, believed to be brought on by the growing use of fossil fuels, is spurring widespread interest in the discovery of electrical fuel-sourcing lithium deposits, and junior explorer QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is advancing toward a production decision that could confirm the viability for commercial production of the lithium-bearing spodumene mineralization at its Irgon project. NOTE TO INVESTORS: The latest news and updates relating to QMCQF are available in the company's newsroom at http://nnw.fm/QMCQF.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.186636, up 8.51%, on 8,300 volume with 5 trades. The average volume for the last 3 months is 48,233 and the stock's 52-week low/high is $0.1155/$0.512.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTC: VPRB), is an innovative technology holding company with a suite of products targeting conscientious vape consumers that are available for purchase on its Vapor Store Direct website (www.VaporStoreDirect.com). To view the full article, visit: http://nnw.fm/Q9cX5.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $0.0798, up 2.70%, on 9,400 volume with 8 trades. The average volume for the last 3 months is 75,035 and the stock's 52-week low/high is $0.026/$0.1397.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently entered into a multiyear extraction services contract with Valens GroWorks Corp. (CSE: VGW) (OTCQB: VGWCF). To view the full article, visit: http://nnw.fm/GD5o4.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.9405, off by 2.31%, on 780,481 volume with 1,123 trades. The average volume for the last 3 months is 1,407,064 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, reported in a press release that its University of Texas MD Anderson Cancer Center collaborators have recorded positive preclinical data in a lung cancer treatment study (http://nnw.fm/8E4bC). The results of the study, which analyzed the combination of the TUSC2 gene and anti-PD1 antibody pembrolizumab, were presented in a poster at the 2019 American Association of Cancer Research Meeting. TUCS2 is a tumor suppressor gene and the active agent in Genprex's Oncoprex immunogene therapy.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.76, off by 2.49%, on 4,954 volume with 36 trades. The average volume for the last 3 months is 49,993 and the stock's 52-week low/high is $0.95/$19.45.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a leading licensed cannabis producer with a diversified portfolio of products and brands, recently secured Health Canada's approval for six additional flowering rooms. This addition brings the company's total production capacity up to 180,000 square feet when measured across 18 flowering rooms. The square footage increase signifies a 50 percent gain from prior production estimates (http://nnw.fm/jm4mL).

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.46, off by 0.81%, on 371,819 volume with 476 trades. The average volume for the last 3 months is 692,103 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTCQB: ETST), an innovative biotechnology company, is increasing the distribution of its full-spectrum CBD product to wider markets, including pharmacies. Cowen & Co. research recently found that independent pharmacies appreciate the high margins and variation from larger chains offered by CBD oils (http://nnw.fm/fD89D). To view the full article, visit: http://nnw.fm/M87Ub.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.57, off by 1.72%, on 14,730 volume with 12 trades. The average volume for the last 3 months is 32,332 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade Inc. (OTC:SGMD) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled "Hemp Boom Spawns Lucrative Deals," please visit: http://cnw.fm/waqL8.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.045, off by 5.06%, on 1,694,606 volume with 97 trades. The average volume for the last 3 months is 1,265,196 and the stock's 52-week low/high is $0.0425/$0.1975.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.